Sie befinden sich:  » Forschung » Publikationen 

Publikationen

Originalarbeiten

1. Kleine T J; <b><b>Worm M</b></b>; Jeep S; Matthiesen F; Lowenstein H; Kunkel G (1993).<br><i>Predominance of the major allergen (Alt a I) in Alternaria sensitized patients.</i><br> Clin Exp Allergy, 23(3):211-8.
2. Schadendorf D; Haas N; <b>Worm M</b>; Ostmeier H; Kohlmus C; Gottschalk J; Algermissen B; Jautzke G; Czarnetzki B M (1993). <br><i>Amelanotic malignant melanoma presenting as malignant schwannoma. </i><br> Brit J Dermatol., 129(5):609-14.
3. Schadendorf D; Moller A; Algermissen B; <b>Worm M</b>; Sticherling M; Czarnetzki B M (1993).<br> <i>IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.</i><br> J Immunol., 1;151(5):2667-75.
4. Schadendorf D; <b>Worm M</b>; Czarnetzki B M (1993).<br> <i>Brain metastases of metastatic malignant melanoma: response to DTIC and interferon-gamma. </i><br>J Neuro-Oncol., 16(1):77-9.
5. Schadendorf D; <b>Worm M</b>; Czarnetzki B M (1993).<br> <i>Determination of granulocyte/macrophage-colony-stimulating factor secretion by human melanoma cells and its effects on human melanoma cell proliferation. </i><br>J Cancer Res Clin Oncol., 119(8):501-3.
6. <b>Worm M</b>; Reichert U; Dippel E; Czarnetzki B M; Schadendorf D (1993).<br><i>Expression of growth factor receptors on human melanoma cells: comparison of modulating effects of interferons and retinoids. </i><br>Exp Dermatol., 2(5):217-23.
7. <b>Worm M</b>; Schadendorf D; Czarnetzki B M (1993). <br><i>Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype.</i><br> Melanoma Res., 3(1):29-33.
8. Bohm M; Moller P; Kalbfleisch U; <b>Worm M</b>; Czarnetzki B M; Schadendorf D (1994). <br><i>Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells. </i><br>Br J Cancer, 70(1):54-9.
9. Orskov L; <b>Worm M</b>; Schmitz O; Mengel A; Sidenius P (1994). <br><i>Nerve conduction velocity in man: influence of glucose, somatostatin and electrolytes. </i><br> Diabetologia, 37(12):1216-20.
10. Schadendorf D; Jurgovsky K; <b>Worm M</b>; Czarnetzki B M (1994).<br><i>In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons. </i><br>Melanoma Res., 4(4):243-9.
11. Schadendorf D; <b>Worm M</b>; Algermissen B; Kohlmus C M; Czarnetzki B M (1994).<br><i>Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.</i><br>Cancer, 1;73(1):103-8.
12. Worm; Geha RS (1994).<br><i>CD40 ligation induces lymphotoxin alpha gene expression in human B cells. </i><br>Int Immunol., 6(12):1883-90.
13. Ramesh N; Morio T; Fuleihan R; <b>Worm M</b>; Horner A; Tsitsikov E; Castigli E; Geha R S (1995) <br><i>CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1). Clin Immunol Immunopathol., 76(3 Pt 2):S208-13.
14. Schadendorf D; <b>Worm M</b>; Jurgovsky K; Dippel E; Reichert U; Czarnetzki B M (1995). <br><i>Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. </i><br>Recent Results Cancer Res., 139:183-93.
15. <b>Worm M</b>; Geha R S (1995). <br><i>Activation of tumor necrosis factor-alpha and lymphotoxin-alpha via anti-CD40 in human B cells. </i><br>Int Arch Allergy Immunol., 107(1-3):368-9.
16. <b>Worm M</b>; Geha R S (1995). <br><i>CD40-mediated lymphotoxin alpha expression in human B cells is tyrosine kinase dependent.</i><br> Eur J Immunol., 25(9):2438-44.
17. <b>Worm M</b>; Makki A; Dippel E; Czarnetzki B M; Schadendorf D (1995). <br><i>Interferon-gamma downregulates epidermal growth factor receptors on human melanoma cells. </i><br> Exp Dermatol., 4(1):30-5.
18. Schadendorf D; Kern M A; Artuc M; Pahl H L; Rosenbach T; Fichtner I; Nurnberg W; Stuting S; von Stebut E; <b>Worm M</b>; Makki A; Jurgovsky K; Kolde G; Henz B M (1996). <br><i>Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. </i><br>J Cell Biol., 135(6 Pt 2):1889-98.
19. Hermes B; <b>Worm M</b>; Nowak F; Kroczek R A; Stein H; Henz B M (1997). <br> <i>Upregulation of CD40 and CD40 ligand expression in IgE-associated cutaneous diseases. </i><br>Acta Derm Venereol., 77(6):441-5.
20. <b>Worm M</b>; Ebermayer K; Henz B (1998). <br><i>Lymphotoxin-alpha is an important autocrine factor for CD40 + interleukin-4-mediated B-cell activation in normal and atopic donors. </i><br>Immunology, 94(3):395-402.
21. <b>Worm M</b>; Jeep S; Sterry W; Zuberbier T (1998).<br> <i>Perioral contact dermatitis caused by L-carvone in toothpaste. </i><br>Contact Dermatitis, 38(6):338.
22. <b>Worm M</b>; Krah J M; Manz R A; Henz B M (1998). <br><i>Retinoic acid inhibits CD40 + interleukin-4-mediated IgE production in vitro.</i><br>Blood, 1;92(5):1713-20.
23. <b>Worm M</b> M; Tsytsykova A; Geha R S (1998). <br><i>CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. </i><br>Eur J Immunol., 28(3):901-6.
24. <b>Worm M</b>; Muche M; Schulze P; Sterry W; Kolde G (1998) <br><i>Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy. </i><br>Br J Dermatol., 139(4):704-7.
25. Hein U R; Chantraine H S; <b>Worm M</b>; Zuberbier T; Henz B M (1999). <br><i>Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions. </i><br>Acta Derm Venereol., 79(2):139-42.
26. Bunikowski R; Mielke M E; Skarabis H; <b>Worm M</b>; Anagnostopoulos I; Kolde G; Wahn U; Renz H (2000).<br><i>Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. </i><br>J Allergy Clin Immunol., 105(4):814-9.
27. Oberwalleney G; Henz B M; <b>Worm M</b> (2000). <br><i>Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors. </i><br>Acta Derm Venereol., 80(4):287-91.
28. <b>Worm M</b>; Ehlers I; Sterry W; Zuberbier T (2000). <br><i>Clinical relevance of food additives in adult patients with atopic dermatitis. </i><br>Clin Exp Allergy, 30(3):407-14.
29. <b>Worm M</b>; Sterry W; Zuberbier T (2000). <br><i>Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine. </i><br>Acta Derm Venereol., 80(3):232.
30. Ehlers I; <b>Worm M</b>; Sterry W; Zuberbier T (2001). <br><i>Sugar is not an aggravating factor in atopic dermatitis.</i><br> Acta Derm-Venereol., 81(4):282-4.
31. <b>Worm M</b>; Herz U; Krah J M; Renz H; Henz B M (2001). <br><i>Effects of retinoids on in vitro and in vivo IgE production. </i><br>Int Arch Allergy Immunol., 124(1-3):233-6.
32. <b>Worm M</b>; Vieth W; Ehlers I; Sterry W; Zuberbier T (2001). <br><i>Increased leukotriene production by food additives in patients with atopic dermatitis and proven food intolerance.</i><br> Clin Exp Allergy, 31(2):265-73.
33. Henz B M; Maurer M; Lippert U; <b>Worm M</b>; Babina M (2001). <br><i>Mast cells as initiators of immunity and host defense. </i><br>Exp Dermatol., 10(1):1-10.
34. Ehlers I; Forschner K; Zuberbier T; Sterry W; <b>Worm M</b> (2001). <br><i>Ernährungsstatus bei erwachsenen Patienten mit atopischer Dermatitis. </i><br>Hautarzt, 53(3):183-8.
35. Ehlers I; Forschner K; Zuberbier T; Sterry W; <b>Worm M</b> (2002). <br><i>[Nutritional status of adult patients with atopic dermatitis]. </i><br>Hautarzt, 53(3):183-8.
36. Ehlers I; Hipler U C; Zuberbier T; <b>Worm M</b> (2002).<br> <i>Ethanol as a cause of hypersensitivity reactions to alcoholic beverages. </i><br>Clin Exp Allergy, 32(8):1231-5.
37. Frotscher B; Anton K; <b>Worm M</b> (2002). <br><i>Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors. </i><br>J Invest Dermatol., 119(5):1059-64.
38. Heine G; Anton K; Henz B M; <b>Worm M</b> (2002). <br><i>1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. </i><br>Eur J Immunol., 32(12):3395-404.
39. Roever A.C; Henz B M; <b>Worm M</b> (2002). <br><i>Wasp venom rush immunotherapy induces transient downregulation of B cell surface molecule expression. </i><br>Int Arch Allergy Immunol., 127(3):226-33.
40. Rover A C; Reimann S; Zuberbier T; <b>Worm M</b> (2002).<br> <i>Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid A.</i><br> J Invest Allerg Clin., 12(4):227-34.
41. <b>Worm M</b> (2002). <br><i>Novel therapies for atopic eczema. </i><br>Curr Opin Investig Drugs, 3(11):1596-603.
42. Zuberbier T; Pfrommer C; Specht K; Vieths S; Bastl-Borrmann R; <b>Worm M</b>; Henz B M (2002). <br> <i>Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. </i><br>J Allergy Clin Immunol., 109(2):343-8.
43. Bogner L; <b>Worm M</b> (2003). <br><i>Fragebogengestützte Analyse zur Häufigkeit und Entstehung von Handekzemen in der Arbeitspraxis. </i><br>Akt Dermatol., 29:163-168.
44. Docke W D; Kiessling C; <b>Worm M</b>; Friedrich M; Pruss A; Weitz M; Prosch S; Kern F; Volk H D; Sterry W; Asadullah K (2003). <br><i>Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis. </i><br>Br J Dermatol., 148(5):954-63.
45. Garcia A L; Ruhl R; Herz U; Koebnick C; Schweigert F J; <b>Worm M</b> (2003). <br><i>Retinoid- and carotenoid-enriched diets influence the ontogenesis of the immune system in mice.</i><br> Immunology, 110(2):180-7.
46. Roever A C; Heine G; Zuberbier T; <b>Worm M</b> (2003). <br><i>Allergen-mediated modulation of CD23 expression is interferon-gamma and interleukin-10 dependent in allergic and non-allergic individuals. </i><br>Clin Exp Allergy, 33(11):1568-75.
47. Ruhl R; Dahten A; Schweigert F J; Herz U; <b>Worm M</b> (2003). <br><i>Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands. </i><br>J Invest Dermatol., 121(4):757-64.
48. Goetze S; Schmook T; Audring H; Ziegenbein C; <b>Worm M</b>; Schulze P (2004). <br><i>[Successful treatment of Stewart-Treves syndrome with liposomal doxorubicin].</i><br> J Dtsch Dermatol Ges., 2(1):49-52.
49. Heine G; Schnuch A; Uter W; <b>Worm M</b> (2004). <br><i>Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. </i><br>Contact Dermatitis, 51(3):111-7.
50. Meurer M; Fartasch M; Albrecht G; Vogt T; <b>Worm M</b>; Ruzicka T; Altmeyer P J; Schneider D; Weidinger G; Braeutigam M; CASM-DE-01 S.G (2004).<br><i>Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis.</i><br> Dermatology, 208(4):365-72.
51. Mittag D; Niggemann B; Sander I; Reese I; Fiedler E M; <b>Worm M</b>; Vieths S; Reese G (2004). <br><i>Immunoglobulin E-reactivity of wheat-allergic subjects (baker's asthma, food allergy, wheat-dependent, exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility. </i><br>Mol Nutr Food Res., 48(5):380-9.
52. Roehr C C; Edenharter G; Reimann S; Ehlers I; <b>Worm M</b>; Zuberbier T; Niggemann B (2004). <br><i>Food allergy and non-allergic food hypersensitivity in children and adolescents. </i><br>Clin Exp Allergy, 34(10):1534-41.
53. Ruhl R; Garcia A; Schweigert F J; <b>Worm M</b> (2004). <br><i>Modulation of cytokine production by low and high retinoid diets in ovalbumin-sensitized mice.</i><br> Int J Vitam Nutr Res., 74(4):279-84.
54. von Pelchrzin R; Soost S; <b>Worm M</b> (2004). <br><i>Klinischer Hautzustand bei Beschäftigten im Gesundheitswesen und der Einfluss von Präventionsmaßnahmen. </i><br>Dermatologie in Beruf und Umwelt, 1:26-32
55. Zuberbier T; Edenharter G; <b>Worm M</b>; Ehlers I; Reimann S; Hantke T; Roehr C C; Bergmann K E; Niggemann B (2004).<br><i>Prevalence of adverse reactions to food in Germany - a population study. </i><br>Allergy, 59(3):338-45.
56. Mittag D; Niggemann B; Sander I; Reese I; Fiedler E M; <b>Worm M</b>; Vieths S; Reese G (2004). <br><i>IgE-reactivity of wheat-allergic subject (baker's asthma, food allergy, wheat-dependent exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility.</i><br> Mol. Nutr. Food Res., 48(5):380-9.
57. Buning C; Genschel J; Jurga J; Fiedler T; Voderholzer W; Fiedler E M; <b>Worm M</b>; Weltrich R; Lochs H; Schmidt H; Ockenga J (2005). <br><i>Introducing genetic testing for adult-type hypolactasia. </i><br>Digestion, 71(4):245-50.
58. Foerster J; Fleischanderl S; Wittstock S; Storch A; Meffert H; Riemekasten G; <b>Worm M</b>; <br><i>Infrared-mediated hyperthermia is effective in the treatment of scleroderma-associated Raynaud's phenomenon. </i><br>J Invest Dermatol., 125(6):1313-6.
59. Frentsch M; Arbach O; Kirchhoff D; Moewes B; <b>Worm M</b>; Rothe M; Scheffold A; Thiel A (2005). <br><i>Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. </i><br>Nat Med., 11(10):1118-24.
60. Lee H.H; Sterry W; <b>Worm M</b> (2005). <br><i>Efficacy of tracrolimus 0.1% ointment in prurigo. J Dtsch Dermatol Ges., 3(9):690-4.
61. Scheffel F; Heine G; Henz B M; <b>Worm M</b> (2005). <br><i>Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production. </i><br>Inflamm Res., 54(3):113-8.
62. Schmook T; Jacobi U; Lademann J; <b>Worm M</b>; Stockfleth E (2005).<br> <i>Detection of doxorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia. </i><br>Dermatology, 210(3):237-8.
63. Schnuch A; Kelterer D; Bauer A; Schuster C; Aberer W; Mahler V; Katzer K; Rakoski J; Jappe U; Krautheim A; Bircher A; Koch P; <b>Worm M</b>; Loffler H; Hillen U; Frosch P J; Uter W (2005).<br><i>Quantitative patch and repeated open application testing in methyldibromo glutaronitrile-sensitive patients. </i><br>Contact Dermatitis, 52(4):197-206.
64. <b>Worm M</b>; Brasch J; Geier J; Uter W; Schnuch A (2005). <br><i>Epikutantestung mit der DKG-Standardreihe 2001-2004. Ergebnisse des IVDK. </i><br>Hautarzt, 56(12):1114-24.
65. Foerster J; Storch A; Fleischanderl S; Wittstock S; Pfeiffer S; Riemekasten G; <b>Worm M</b> (2006). <br><i>Neutrophil respiratory burst is decreased in scleroderma and normalized by near-infrared mediated hyperthermia. </i><br>Clin Exp Dermatol., 31(6):799-806.
66. Foerster J; Wittstock S; Fleischanderl S; Storch A; Riemekasten G; Hochmuth O; Meffert B; Meffert H; <b>Worm M</b> (2006).<br><i>Infrared-monitored cold response in the assessment of Raynaud's phenomenon. </i><br>Clin Exp Dermatol., 31(1):6-12.
67. Heine G; Schnuch A; Uter W; <b>Worm M</b>; Information N;o.D.o.D. (IVDK); German C.D.R.G. (DKG) (2006).<br><i>Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). </i><br>Allergy, 61(5):611-6.
68. Kary S; <b>Worm M</b>; Audring H; Huscher D; Renelt M; Sörensen H; Ständer E; Maass U; Lee H; Sterry W; Burmester G.R (2006).<br><i>New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. </i><br>Ann Rheum Dis., 65(3):405-7. Epub 2005 Sep 8.
69. Kirschbaum J; Forschner K; Rasche C; <b>Worm M</b> (2006). <br><i>Modulation of lymphocyte phenotype and function by immunoglobulins. </i><br>Br J Dermatol., 154(2):225-30.
70. Lee H; Roediger C; Bauer A; Zuberbier T; <b>Worm M</b> (2006). <br><i>Prospective safety analysis of an ultrarush specific immunotherapy in adults with wasp venom allergy.</i><br> Allergy, 61(10):1237-8.
71. Marenholz I; Nickel R; Rüschendorf F; Schulz F; Esparza-Gordillo J; Kerscher T; Grüber C; Lau S; <b>Worm M</b>; Keil T; Kurek M; Zaluga E; Wahn U; Lee Y A (2006).<br><i>Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. </i><br>J Allergy Clin Immunol., 118(4):866-71.
72. Schmidt M; Anton K; Nordhaus C; Junghans C; Wittig B; <b>Worm M</b> (2006). <br><i>Cytokine and Ig-production by CG-containing sequences with phosphorodiester backbone and dumbbell-shape. </i><br>Allergy, 61(1):56-63.
73. Werfel T; Breuer K; Ruéff F; Przybilla B; <b>Worm M</b>; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A (2006).<br><i>Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. </i><br>Allergy, 61(2):202-5.
74. <b>Worm M</b> (2006). <br><i>Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. </i><br> Eur Ann Allergy Clin Immunol., 38(10):355-60.
75. <b>Worm M</b>; Forschner K; Lee H H; Roehr C C; Edenharter G; Niggemann B; Zuberbier T (2006). <br><i>Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. </i><br>Acta Derm Venereol., 86(2):119-22.
76. Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; <b>Worm M</b>; Arcangeli F (2007).<br> <i>Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. </i><br>Allergy, 62(2):184-9.
77. Dahten A; Mergemeier S; <b>Worm M</b> (2007). <br><i>PPARgamma expression profile and its cytokine driven regulation in atopic dermatitis. </i><br>Allergy, 62(8):926-33.
78. Didier A; Malling H J; <b>Worm M</b>; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M (2007).<br><i>Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. </i><br>J Allergy Clin Immunol., 120(6):1338-45.
79. Foerster J; Kuerth A; Niederstrasser E; Krautwald E; Pauli R; Paulat R; Eweleit M; Riemekasten G; <b>Worm M</b> (2007).<br><i>A cold-response index for the assessment of Raynaud's phenomenon. </i><br>J Dermatol Sci., 45(2):113-20.
80. Jacobi U; Engel K; Patzelt A; <b>Worm M</b>; Sterry W; Lademann J (2007).<br> <i>Penetration of pollen proteins into the skin. </i><br>Skin Pharmacol Physiol., 20(6):297-304.
81. Klinger R; Soost S; Flor H; <b>Worm M</b> (2007). <br><i>Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin.</i><br> Pain, 128(1-2):31-9.
82. Lee H H; Song I H; Friedrich M; Gauliard A; Detert J; Röwert J; Audring H; Kary S; Burmester G R; Sterry W; <b>Worm M</b> (2007).<br><i>Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. </i><br>Br J Dermatol., 156(3):486-91.
83. Rasche C; Wolfram C; Wahls M; <b>Worm M</b> (2007). <br><i>Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response. </i><br>Acta Derm Venereol., 87(4):305-11.
84. Rühl R; Hänel A; Garcia A L; Dahten A; Herz U; Schweigert F J; <b>Worm M</b> (2007). <br><i>Role of vitamin A elimination or supplementation diets during postnatal development on the allergic sensitisation in mice. </i><br>Mol Nutr Food Res., 51(9):1173-81.
85. Söderhäll C; Marenholz I; Kerscher T; Rüschendorf F; Esparza-Gordillo J; <b>Worm M</b>; Gruber C; Mayr G; Albrecht M; Rohde K; Schulz H; Wahn U; Hubner N; Lee Y A (2007).<br><i>Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. </i><br>PLoS Biol., 5(9):e242.
86. Soost S; Graupner I; Morch-Röder A; Pohrt U; <b>Worm M</b> (2007). <br><i>A 7-step consultation plan for health care workers and hairdressers. </i><br> J Dtsch Dermatol Ges., 5(9):756-60.
87. Dahten A; Koch C; Ernst D; Schnöller C; Hartmann S; <b>Worm M</b> (2008). <br><i>Systemic PPARgamma ligation inhibits allergic immune response in the skin. </i><br>J Invest Dermatol., 128(9):2211-8.
88. Eis D; Helm D; Mühlinghaus T; Birkner N; Dietel A; Eikmann T; Gieler U; Herr C; Lacour M; Nowak D; Pedrosa Gil F; Podoll K; Renner B; Andreas Wiesmüller G; <b>Worm M</b> (2008).<br><i>The German Multicentre Study on Multiple Chemical Sensitivity (MCS). </i><br>Int J Hyg Environ Health, 211(5-6):658-81.
89. Heine G; Niesner U; Chang H D; Steinmeyer A; Zügel U; Zuberbier T; Radbruch A; <b>Worm M</b> (2008).<br><i>1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. </i><br>Eur J Immunol., 38(8):2210-8.
90. Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Moinzadeh P; Müller-Ladner U; Pfeiffer C; Riemekasten G; Schulze-Lohoff E; Sunderkoetter C; Weber M; <b>Worm M</b>; Klaus P; Rubbert A; Steinbrink K; Grundt B; Hein R; Scharffetter-Kochanek K; Hinrichs R; Walker K; Szeimies R M; Karrer S; Müller A; Seitz C; Schmidt E; Lehmann P; Foeldvári I; Reichenberger F; Gross W L; Kuhn A; Haust M; Reich K; Böhm M; Saar P; Fierlbeck G; Kötter I; Lorenz H M; Blank N; Gräfenstein K; Juche A; Aberer E; Bali G; Fiehn C; Stadler R; Bartels V; Registry o.t.G.N.f.S.S (2008).<br><i>The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. </i><br>Rheumatology (Oxford), 47(8):1185-92. Epub 2008 May 31.
91. Koch C; Dölle S; Metzger M; Rasche C; Jungclas H; Rühl R; Renz H; <b>Worm M</b> (2008). <br><i>Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial. </i><br>Br J Dermatol., 158(4):786-92. Epub 2008 Jan 30.
92. Rühl R; Koch C; Marosvölgyi T; Mihály J; Schweigert F J; <b>Worm M</b>; Decsi T (2008).:<br> <i>Fatty acid composition of serum lipid classes in mice following allergic sensitisation with or without dietary docosahexaenoic acid-enriched fish oil substitution. </i><br>Br J Nutr., 99(6):1239-46.
93. <b>Worm M</b> (2008). <br><i>[Allergic skin reactions. Current survey]. </i><br>Deut Med Wochenschr., 133 Suppl 3:S63-6.
94. <b>Worm M</b>; Hompes S; Vogel N; Kirschbaum J; Zuberbier T (2008). <br><i>Care of anaphylaxis among practising doctors. </i><br>Allergy, 63(11):1562-3.
95. Bässler O.Y; Weiss J; Wienkoop S; Lehmann K; Scheler C; Dölle S; Schwarz D; Franken P; George E; <b>Worm M</b>; Weckwerth W (2009).<br><i>Evidence for novel tomato seed allergens: IgE-reactive legumin and vicilin proteins identified by multidimensional protein fractionation-mass spectrometry and in silico epitope modeling. </i><br>J Proteome Res., 8(3):1111-22.
96. Brandt C; Pavlovic V; Radbruch A; <b>Worm M</b>; Baumgrass R (2009) <br><i>Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. </i><br>Allergy, 64(11):1588-96.
97. Didier A; Melac M; Montagut A; Lhéritier-Barrand M; Tabar A; <b>Worm M</b> (2009). <br><i>Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. </i><br>Allergy, 64(1):166-71.
98. Hanitsch LG; Burmester G R; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; DNSS C; Riemekasten G (2009).<i>Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. </i><br>Rheumatology, 48(1):70-3.
99. Hartmann S; Schnoeller C; Dahten A; Avagyan A; Rausch S; Lendner M; Bocian C; Pillai S; Loddenkemper C; Lucius R; <b>Worm M</b>; Hamelmann E (2009).<br><i>Gastrointestinal nematode infection interferes with experimental allergic airway inflammation but not atopic dermatitis. </i><br>Clin Exp Allergy, 39(10):1585-96.
100. Heine G; Dahten A; Hilt K; Ernst D; Milovanovic M; Hartmann B; <b>Worm M</b> (2009). <br><i>Liver X receptors control IgE expression in B cells.</i><br> J Immunol., 1;182(9):5276-82.
101. Hompes S; Beyer K; Köhli A; Nemat K; Scherer K; Lange L; Rietschel E; Reese T; <b>Worm M</b> (2009).<br><i>Anaphylaxie im Kindes- und Jugendalter, Symptome, Auslöser und Therapie. </i><br>Kinder- und Jugendmedizin, 9:393-399.
102. Horak F; Jaeger S; <b>Worm M</b>; Melac M; Didier A (2009). <br><i>Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. </i><br>Clin Exp Allergy, 39(3):394-400.
103. Kopp M V; Hamelmann E; Zielen S; Kamin W; Bergmann K C; Sieder C; Stenglein S; Seyfried S; Wahn U; DUAL study group (2009).<br><i>Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.</i><br> Clin Exp Allergy, 39(2):271-9.
104. Kuhn A; Kuehn E; Meuth A M; Haust M; Nyberg F; Werth V; Ruzicka T; Schmitt V; Bonsmann G; EUSCLE S G; Collaborators (2009).<br><i>Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE.) </i><br>Autoimmun Rev:., 8(8):702-12.
105. Lademann J; Patzelt A; <b>Worm M</b>; Richter H; Sterry W; Meinke M (2009). <br><i>Analysis of in vivo penetration of textile dyes causing allergic reactions </i><br>Laser Physics, Lett 6. No. 10:759-763.
106. Lee H I; <b>Worm M</b> (2009). <br><i>Advances in the management of UVR-associated skin cancers: autoimmune diseases and UV protection. </i><br>Br J Dermatol., 161 Suppl 3:96-8.
107. Luger E O; Fokuhl V; Wegmann M; Abram M; Tillack K; Achatz G; Manz R A; <b>Worm M</b>; Radbruch A; Renz H (2009).<br><i>Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. </i><br>J Allergy Clin Immunol., 124(4):819-26.e4.
108. Milovanovic M; Heine G; Zuberbier T; <b>Worm M</b> (2009). <br><i>Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. </i><br>Clin Exp Allergy, 39(5):671-8.
109. Oh D Y; Schumann R R; Hamann L; Neumann K; <b>Worm M</b>; Heine G (2009). <br><i>Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis. </i><br>Allergy, 64(11):1608-15.
110. Schnuch A; Szliska C; Uter W; Collaborators (2009).<br><i>[Facil allergic contact dermatitis. Data from the IVDK and review of literature]. </i><br>Hautarzt, 60(1):13-21.
111. Schnuch A; Uter W; Dickel H; Szliska C; Schliemann S; Eben R; Ruëff F; Gimenez-Arnau A; Löffler H; Aberer W; Frambach Y; <b>Worm M</b>; Niebuhr M; Hillen U; Martin V; Jappe U; Frosch P J; & Mahler V (2009).<br><i>Quantitative patch and repeated open application testing in hydroxyisohexyl 3-cyclohexene carboxaldehyde sensitive-patients.</i><br> Contact Dermatitis, 61(3):152-62.
112. Soost S; Leynaert B; Almqvist C; Edenharter G; Zuberbier T; <b>Worm M</b> (2009). <br><i>Risk factors of adverse reactions to food in German adults. </i><br>Clin Exp Allergy, 39(7):1036-44.
113. Sunderkötter C; Herrgott I; Brückner C; Moinzadeh P; Pfeiffer C; Gerss J; Hunzelmann N; Böhm M; Krieg T; Müller-Ladner U; Genth E; Schulze-Lohoff E; Meurer M; Melchers I; Riemekasten G; & DNSS C (2009).<br><i>Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. </i><br>Br J Dermatol., 160(4):835-43.
114. Werfel T; Aberer W; Augustin M; Biedermann T; Fölster-Holst R; Friedrichs F; Gieler U; Heratizadeh A; Kapp A; Przybilla B; Rietschel E; Schlaeger M; Schmid-Grendelmeier P; Sitters H; Staab D; Szczepanski R; Vieluf D; Voigtmann I; <b>Worm M</b> (2009).<br><i>[Atopic dermatitis: S2 guidelines]. </i><br>J Dtsch Dermatol Ges., 7 Suppl 1:S1-46.
115. Wolfram C; Rasche C; Audring H; Wahls M; <b>Worm M</b> (2009). <br><i>Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis.</i><br> Eur Arch Otorhinolaryngol., 266(5):677-83.
116. <b>Worm M</b> (2009). <br><i>'Well days' after sublingual immunotherapy with a high-dose 6-grass pollen preparation. </i><br>Allergy, 64(7):1104-5.
117. <b>Worm M</b> (2009). <br><i>Verträglichkeit der spezifischen Immuntherapie während der Umstellung von lyophilisiertem Wespengift auf ein Depotpräparat. </i><br>Allergologie, 4:143-145.
118. <b>Worm M</b>; Fiedler E M; Dölle S; Schink T; Hemmer W; Jarisch R; Zuberbier T (2009). <br><i>Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis. </i><br>Acta Derm Venereol., 89(1):52-6.
119. <b>Worm M</b>; Hompes S; Fiedler E M; Illner A K; Zuberbier T; Vieths S (2009). <br><i>Impact of native, heat-processed and encapsulated hazelnuts on the allergic response in hazelnut-allergic patients. </i><br>Clin Exp Allergy, 39(1):159-66.
120. Avouac J; Walker U; Tyndall A; Kahan A; Matucci-Cerinic M; Allanore Y; Miniati I; Muller A; Iannone F; Distler O; Becvar R; Sierakowsky S; Kowal-Bielecka O; Coelho P; Cabane J; Cutolo M; Shoenfeld Y; Valentini G; Rovensky J; Riemekasten G; Vlachoyiannopoulos P; Caporali R; Jiri S; Inanc M; Zimmermann Gorska I; Carreira P; Novak S; Czirjak L; Oliveira Ramos F; Jendro M; Chizzolini C; Kucharz E.J; Richter J; Cozzi F; Rozman B; Mallia C.M; Gabrielli A; Farge D; Kiener H P; Schöffel D; Airo P; Wollheim F; Martinovic D; Trotta F; Jablonska S; Reich K; Bombardieri S; Siakka P; Pellerito R; Bambara L M; Morovic-Vergles J; Denton C; Hinrichs R; Van den Hoogen F; Damjanov N; Kötter I; Ortiz V; Heitmann S; Krasowska D; Seidel M; Hasler P; Van Laar J M; Kaltwasser J P; Foeldvari I; Juan Mas A; Bajocchi G; Wislowska M; Pereira Da Silva J A; Jacobsen S; <b>Worm M</b>; Graniger W; Kuhn A; Stankovic A; Cossutta R; Majdan M; Damjanovska Rajcevska L; Tikly M; Nasonov E L; Steinbrink K; Herrick A; Müller-Ladner U; Dinc A; Scorza R; Sondergaard K; Indiveri F; Nielsen H; Szekanecz Z; Silver R M; Antivalle M; Espinosa I B; García de la Pena Lefebvre P; Midtvedt O; Launay D; Valesini F; Tuvik P; Ionescu R M; Del Papa N; Pinto S; Wigley F; Mihai C; Sinziana Capranu M; Sunderkötter C; Jun J B; Alhasani S; Distler J H; Ton E; Soukup T; Seibold J; Zeni S; Nash P; Mouthon L; De Keyser F; Duruöz M T; Cantatore F P; Strauss G; von Mülhen C A.; Pozzi M R; Eyerich K; Szechinski J; Keiserman M; Houssiau F A; Román-Ivorra J A; Krummel-Lorenz B; Aringer M; Westhovens R; Bellisai F; Mayer M; Stoeckl F; Uprus M; Volpe A; Buslau M; Yavuz S; Granel B; Valderílio Feijó A; Del Galdo F; Popa S; Zenone T; Ricardo Machado X; Pileckyte M; Stebbings S; Mathieu A; Tulli A; Tourinho T; Souza R; Acayaba de Toledo R; Stamp L; Solanki K; Veale D; Francisco Marques Neto J; Bagnato G F; Loyo E; Toloza S; Li M; Ahmed Abdel Atty Mohamed W; Cobankara; Olas J; Salsano F; Oksel F; Tanaseanu C M; Foti R;Ancuta C; Vonk M; Caramashi P; Beretta L; Balbir A; Chiàla A; Pasalic Simic K; Ghio M; Stamenkovic B; Rednic S; Host N; Pellerito R; Hachulla E; Furst D E (2010).<br><i>Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. </i><br>J Rheumatol, 37(7):1488-501.
121. Babina M; Kirn F; Hoser D; Ernst D; Rohde W; Zuberbier T; <b>Worm M</b> (2010). <br> <i>Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice. </i><br>Clin Exp Allergy, 40(8):1256-65.
122. Bissonnette R; <b>Worm M</b>; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown T C (2010).:<br><i>Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. </i><br>Br J Dermatol., 1;162(2):420-6.
123. Brandt C; Liman P; Bendfeldt H; Mueller K; Reinke P; Radbruch A; <b>Worm M</b>; Baumgrass R (2010). <br><i>Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells.</i><br> Cytometry A., 77(7):607-13.
124. Brehler R; Klimek L; Pfaar O; Hauswald B; <b>Worm M</b>; Bieber T (2010). <br><i>Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts. </i><br>Allergy Asthma Proc, 31(3):e31-8.
125. Brueckner C S; Becker M O; Kroencke T; Huscher D; Scherer H U; <b>Worm M</b>; Burmester G; Riemekasten G (2010).<br><i>Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study. </i><br>Ann Rheum Dis., 69(8):1475-8.
126. Dickel H; Kreft B; Kuss O; <b>Worm M</b>; Soost S; Brasch J; Pfützner W; Grabbe J; Angelova-Fischer I; Elsner P; Fluhr J; Altmeyer P; Geier J (2010).<br><i>Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study. </i><br>Contact Dermatitis, 62(5):294-302.
127. Dölle S; Hoser D; Rasche C; Loddenkemper C; Maurer M; Zuberbier T; <b>Worm M</b> (2010). <br><i>Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis. </i><br>Allergy, 65(9):1158-65.
128. Foelster Holst R; Reitamo S; Yankova R; <b>Worm M</b>; Kadurina M; Thaci D; Thaci K; Bieber T; Tsankov N; Enk A; Luger T; Duffy M; Tansley R (2010).<br><i>The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study.</i><br>Allergy, 65(12):1594-9. doi: 10.1111/j.1398-9995.2010.02417.x.
129. Heine G; Lahl A; Müller C; <b>Worm M</b> (2010).<br> <i>Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. </i><br>Br J Dermatol., 163(4):863-5.
130. Heratizadeh A; Killig C; <b>Worm M</b>; Soost S; Simon D; Bauer A; Mahler V; Schuster C; Szliska C; Frambach Y; Eben R; Werfel T; Uter W; Schnuch A (2010).<br><i>Quantitative repeated open application testing with a rinse-off product in methyldibromo glutaronitrile-sensitive patients: results of the IVDK.</i><br> Contact Dermatitis, 62(6):330-7.
131. Krause K; Ardelean E; Keßler B; Magerl M; Metz M; Siebenhaar F; Weller K; <b>Worm M</b>; Zuberbier T; Maurer M (2010).<br><i>Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. </i><br>Allergy, 65(11):1494-5.
132. Milovanovic M; Drozdenko G; Weise C; Babina M; <b>Worm M</b> (2010). <br><i>Interleukin-17A promotes IgE production in human B cells. </i><br>J Invest Dermatol., 130(11):2621-8.
133. Milovanovic M; Heine G; Hallatschek W; Opitz B; Radbruch A; <b>Worm M</b> (2010). <br><i>Vitamin D receptor binds to the germline gene promoter and exhibits transrepressive activity.</i><br> J Allergy Clin Immunol., 126(5):1016-23, 1023.e1-4.
134. Ruppel E; Aÿ B; Boisguerin P; Dölle S; <b>Worm M</b>; Volkmer R (2010). <br><i>Identification of IgE binding to Api g 1-derived peptides.</i><br> Chembiochem, 2;11(16):2283-93.
135. Zuberbier T; Balke M; <b>Worm M</b>; Edenharter G; Maurer M (2010). <br><i>Epidemiology of urticaria: a representative cross-sectional population survey.</i><br> Clin Exp Dermatol., 35(8):869-73. doi: 10.1111/j.1365-2230.2010.03840.x.
136. Hompes S; Scherer K; Köhli A; Rueff F; Mahler V; Lange L; Treudler R; Rietschel E; Szepfalusi Z; Lang R; Rabe U; Reese T; Beyer K; Schwerk N; <b>Worm M</b> (2010).<br><i>Nahrungsmittel-Anaphylaxie: Daten aus dem Anaphylaxie-Register. </i><br>Allergo J., 2010;19:234-42.
137. Breuer K; <b>Worm M</b>; Skudlik C; John S M (2010).<br><i>Ethylenoxid als berufliches Kontaktallergen - ein unterschätztes Problem? </i><br>Allergologie 2010;33(8):331-3360.
138. Didier A; <b>Worm M</b>; Horak F; Sussman G; de Beaumont O; Le Gall M; Melac M; Malling H J (2011). <br><i>Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. </i><br>J Allergy Clin Immunol., 128(3):559-66. Epub 2011 Jul 29.
139. Dölle S; Schwarz D; Lehmann K; Weckwerth W; George E; <b>Worm M</b>; Franken P (2011). <br><i>Tomato allergy: impact of genotype and environmental factors on the biological response. </i><br>J Sci Food Agric., Sep;91(12):2234-40. doi: 10.1002/jsfa.4443.
140. Dölle S; Lehmann K; Schwarz D; Weckwert W; Scheler C; George E; Franken P; <b>Worm M</b> (2011). <br><i>Allergenic activity of different tomato cultivars in tomato allergic subjects. </i><br>Clin Exp Allergy, 41(11):1643-52. doi: 10.1111/j.1365-2222.2011.03841.x.
141. Geldmeyer-Hilt K; Heine G; Hartmann B; Baumgrass R; Radbruch A; <b>Worm M</b> (2011). <br><i>1,25-dihydroxyvitamin D3 impairs NF-KB activation in human naïve B cells. </i><br>Biochem Biophys Res Commun., 22;407(4):699-702.
142. Hartmann B; Heine G; Babina M; Steinmeyer A; Zügel U; Radbruch A; <b>Worm M</b> (2011). <br><i>Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. </i><br>Allergy, 66(4):540-8. doi: 10.1111/j.1398-9995.2010.02513.x.
143. Heine G; Drozdenko G; Lahl A; Unterwalder N; Mei H; Volk H D; Dörner T; Radbruch A, <b>Worm M</b> (2011).<br><i>Efficient tetanus toxoid immunization on vitamin D supplementation. </i><br>Eur J Clin Nutr., 65(3):329-34.
144. Hillen U; Dickel H; Löffler H; Pfützner W; Mahler V; Becker D; Brasch J; <b>Worm M</b>; Fuchs T; John S M; Geier J (2011).<br><i>Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group. </i><br>Contact Dermatitis, 64(4):196-202. doi: 10.1111/j.1600-0536.2010.01855.x.
145. Hompes S; Köhli A; Nemat K; Scherer K; Lange L; Rueff F; Rietschel E; Reese T; Szepfalusi Z; Schwerk N; Beyer K; Hawranek T; Niggemann B; <b>Worm M</b> (2011).<br><i>Provoking allergens and treatment of anaphylaxis in children and adolescents - data from the anaphylaxis registry of German-speaking countries.</i><br>Pediatr Allergy Immunol., 22(6):568-74. doi: 10.1111/j.1399-3038.2011.01154.x.
146. Kuna P; Samolinski B; <b>Worm M</b>; Pfaar O; Klimek L, Study Group (2011). <br><i>Sustained clinical efficacy of sublingual immunotherapy with a high-dose grass pollen extract. </i><br>Eur Ann Allergy Clin Immunol., 43(4):117-21.
147. Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; <b>Worm M</b>; R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E, Hunzelmann N (2011). <br><i>Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features. </i><br>Arthritis Res Ther., 21;13(5):R172.
148. Mihály J; Gamlieli A; <b>Worm M</b>; Rühl R (2011). <br><i>Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis. </i><br>Exp Dermatol., 20(4):326-30. doi: 10.1111/j.1600-0625.2010.01225.x.
149. Schwarz D; Welter S; George E; Franken P; Lehmann K; Weckwerth W; Dölle S; <b>Worm M</b> (2011). <br><i>Impact of arbuscular mycorrhizal fungi on the allergenic potential of tomato. </i><br>Mycorrhiza, 21(5):341-9.
150. Weise C; Heunemann C; Loddenkemper C; Herz U; van Tol E A F; <b>Worm M</b> (2011). <br><i>Dietary docosahexaenoic acid in combination with arachidonic acid ameliorates allergen-induced dermatitis in mice. </i><br>Pediatr Allergy Immunol., 22(5):497-504. doi: 10.1111/j.1399-3038.2010.01133.x.
151. Weise C; Hilt K; Milovanovic M; Ernst D; Rühl R; <b>Worm M</b> (2011). <br><i>Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NF-KB pathway in human B cells. </i><br>J Nutr Biochem., 22(3):269-75.
152. Weise C; Zhu Y; Ernst D; Kühl A A; <b>Worm M</b> (2011). <br><i>Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. </i><br>Exp Dermatol., 20(10):805-9. doi: 10.1111/j.1600-0625.2011.01326.x.
153. <b>Worm M</b>; Lee H H; Kleine-Tebbe J; Hafner R P; Laidler P; Healey D; Buhot C; Verhoef A; Maillère B; Kay A B; Larché M (2011).<br><i>Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. </i><br>J Allergy Clin Immunol., 127(1):89-97, 97.e1-14.
154. Weller K; Soost S; <b>Worm M</b>; Maurer M; Zuberbier T (2012). <br><i>Atopic dermatitis and allergic rhinitis - do co-effects in therapy exist? </i><br>J Dtsch Dermatol Ges., 2012 Apr;10(4):221-39. doi: 10.1111/j.1610-0387.2011.07885.x
155. Soost S; Abdollahnia M; Kostev K; <b>Worm M</b> (2012). <br><i>Topical therapy of hand eczema - analysis of the prescription profile from dermatologists in private practice. </i><br>J Dtsch Dermatol Ges. 2012 Mar;10(3):180-4. doi: 10.1111/j.1610-0387.2011.07787.x.
156. Hartmann B; Riedel R; Jörss K; Loddenkemper C; Steinmeyer A; Zügel U; Babina M; Radbruch A; <b>Worm M</b> (2012). <br><i>Vitamin D receptor activation improves allergen-triggered eczema in mice.</i><br>J Invest Dermatol. 2012 Feb;132(2):330-6. doi: 10.1038/jid.2011.296. Epub 2011 Sep 22.
157. <b>Worm M</b>; Edenharter G; Ruëff F; Scherer K; Pföhler C; Mahler V; Treudler R; Lang R; Nemat K; Koehli A; Niggemann B; Hompes S (2012). <br><i>Symptom profile and risk factors of anaphylaxis in Central Europe.</i><br>Allergy. 2012 May;67(5):691-8. doi: 10.1111/j.1398-9995.2012.02795.x.
158. <b>Worm M</b>; Hompes S (2012). <br><i>[The registry for severe allergic reactions in German-speaking countries. Recent data and perspectives].</i><br>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Mar;55(3):380-4.
159. Dölle S; Hompes S; Grünhagen J; <b>Worm M</b> (2012). <br><i>[Food-associated anaphylaxis : Data from the anaphylaxis registry.]</i><br>Hautarzt. 2012 Mar 21. [Epub ahead of print]

 

Gesamtsumme: 564,648 Impactpunkte (Originalarbeiten), HI-Faktor 25

Anzahl Erstautor: 27 (Kumulativer Impaktfaktor 86,003)
Anzahl Letztautor: 64 (Kumulativer Impaktfaktor 218,379)
Anzahl Coautor: 68 (Kumulativer Impaktfaktor 260,266)

Buchkapitel

1. <b>Worm M</b>, Sterry W (2006). <br><i>Non-Bullous Skin Diseases: Alopecia, Vitiligo, Psoriasis and Urticaria.</i><br>The Autoimmune Diseases, 4. Edition, Elsevier Verlag. S. 807-818.
2. <b>Worm M</b>; Jakob T (2006). <i>Mechanisms of IgE-Regulation. </i><br>Handbook of Atopic Eczema, 2nd Edition, 265-274, Springer Verlag.
3. Lee H; <b>Worm M</b> (2006). <i>Umweltmedizin in der Dermatologie. I </i><br>Beyer A, Eis D. (Hrsg): Praktische Umweltmedizin. Loseblattwerk, Sektion 03.04, S. 1-22. Springer Verlag.
4. <b>Worm M</b> (2006). <i>Sinn und Unsinn von Diätempfehlungen.</i><br>Fortschritte der praktischen Dermatologie und Venerologie, LMU München, Plewig, Gerd; Thomas, P. (Hrsg.).
5. Schaefer H; Lademann J; <b>Worm M</b> (2007).<br><i>Penetration von Allergenen. Kontaktekzem, Dustri-Verlag Dr. Karl Feistle; Fuchs und Aberer (Hrsg.).
6. <b>Worm M</b>. <br><i>Klinische Erfolge bei der hochdosierten sublingualen Immuntherapie. </i><br> Allergologie für die Praxis, Band 12, Lichtnecker (Hrsg.)
7. <b>Worm M</b>. <br><i>Nahrungsmittel als Provokationsfaktor des atopischen Ekzems.</i><br> Fortschritte der praktischen Dermatologie und Venerologie, Springer, Hrsg. Ruzicka T; Wolff H; Thomas P; Prinz J.
8. <b>Worm M</b> (2009).<br><i>Anaphylaxie: Grundlagen und Meldesystem in Nahrungsmittel und Allergie 3.</i><br>Dustri Verlag, B.Wüthrich, Th. Werfel (Hrsg).
9. <b>Worm M</b>; Hompes S (2008).<br><i>Anaphylaxie-Register: Erfahrungen nach 2 Jahren. </i><br>Allergie-Kongreß, Autoren: Jung K, Fuchs Th. Dustri Verlag.
10. Luger EO; Radbruch A; <b>Worm M</b> (2009).<br><i>B cells and allergy. Immunology of Ocular Allergy.</i> New Delhi, India: Jaypee Bro. Publisher.
11. Landeck L; Sterry W; <b>Worm M</b> (2009).<br><i>Dermatologische Untersuchungen.</i><br>Ärztliche Fähigkeiten, Wissenschaftliche Verlagsgesellschaft, Schnabel, Ahlers, Dashti, Georg, Schwantes (Hrsg.).
12. <b>Worm M</b> (2009).<i>Allergy vaccination with peptides--SIT with major cat allergen Fel d 1 peptides: safety, tolerability and dose responses. </i><br>Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M: 96 349-53; discussion 353-4.
13. <b>Worm M</b>. <i>Epidemiology of Anaphylaxis.(2010). <br></i>Chem Immunol Allergy, 95:12-21. Epub 2010 Jun 1.
14. Sterry W; Burgdorf W; Paus R (2010).<br>Checkliste Dermatologie, 6. Auflage, Thieme Verlag.
15. <b>Worm M</b>; Dölle S (2010).<br><i>Klinische Bedeutung der Nahrungsmittelallergene in Allergene in Lebensmitteln.</i><br>Allergologie-Ernährungswissenschaft-Recht-Praxis, Behr's Verlag.
16. <b>Worm M</b>.<br><i>Epidemiologie allergischer Krankheiten: Anaphylaxie.</i><br>Allergologie-Handbuch Grundlagen und klinische Praxis 2. Auflage, Seite 212 - 214, Schattauer Verlag.
17. Heine G; Sims GP; <b>Worm M</b>; Lipsky PE; Radbruch A (2011).<br><i>Isolation of human B cell populations. </i><br>Curr Protoc Immunol,Chapter 7:Unit7.5.
18. Muul LM; Heine G; Silvin C; James SP; Candotti F; Radbruch A; <b>Worm M</b> (2011).<br><i>Measurement of proliferative responses of cultured lymphocytes.</i><br> Curr Protoc Immunol, Chapter 7:Unit7.10.
19. Heine G; Sims G P; <b>Worm M</b>; Lipsky P E; Radbruch A (2011).<br><i>Isolation of human B cell populations. </i><br>Curr Protoc Immunol, Chapter 7 Unit7.5.

Fallberichte

1. <b>Worm M</b>; Kleine-Tebbe A; v Stebut E; Haas N; Kolde G (1998). <br> <i>Multicentric reticulohistiocytosis indicating metastasis of an unknown primary tumour. </i><br> Acta Derm Venerol. (Stockh), 78:67-68.
2. <b>Worm M</b>; Algermissen B; Sterry W; Kolde G (1998). <br><i>Auftreten eines ulcerierten Tumors als Manifestation einer Tuberculosis cutis colliquativa. </i><br>H+G, 73:92-94.
3. <b>Worm M</b>; Jeep S; Sterry W; Zuberbier T (1998). <br><i>Perioral contact dermatitis produced by I-carvone in toothpaste. </i><br>Contact Dermatitis, 38:338.
4. <b>Worm M</b>; Stebut E; Schulze P; Sterry W; Kolde G (1998). <br><i>Hypocomplementemic urticarial vasculitis: Successful treatment with cyclophosphamide-dexamethasone pulse therapy. </i><br>Br J Dermatol., 139:704
5. <b>Worm M</b>; Skarabis W; Audring H; Sterry W; Kolde G (1999). <br> <i>Nevoid bag-like soft fibromas. </i><br>Dermatology, 199:167-8.
6. <b>Worm M</b>; Sterry W; Zuberbier T (2000). <br><i>Gelatin induced urticaria and anaphylaxis after tick-borne encephalitis vaccine. </i><br>Acta Derm Venerol., 80:232.
7. <b>Worm M</b>; Sterry W; Kolde G (2000). <br><i>Mycophenolate mofetil is effective for maintenance therapy of hypocomplementemic urticaria vascultitis. </i><br>Br J Dermatol., 143:1324.
8. Meyer L; Zuberbier T; <b>Worm M</b>; Oettle H; Riess H (2002). <br><i>Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule. </i><br>J Clin Oncol., 20(4):1146-7.
9. Fiedler EM; Zuberbier T; <b>Worm M</b> (2002). <br><i>A combination of wheat flour, ethanol and food additives inducing FDEIA. </i><br>Allergy, 57:1090-1091.
10. Forschner K; Zuberbier T; <b>Worm M</b> (2003). <br><i>Benzyolperoxid als Ursache einer Airborne-Kontaktdermatitis bei einem Orthopädiemechaniker. </i><br>Akt Dermatol., 29:195-196.
11. Fischer TC; <b>Worm M</b>; Groneberg DA (2003). <br><i>Clopidogrel-associated angioedema. Am J Med., 114:77-78.
12. Forschner K; Kleine-Tebbe J; Zuberbier T; <b>Worm M</b> (2003). <br><i>Type I sensitization towards patents blue as a cause of anaphylaxis.</i><br>Allergy, 58:457-458.
13. <b>Worm M</b>; Kolde G (2003). <br><i>Schnitzler's syndrome: successful treatment of two patients using thalidomide. </i><br>Br J Dermatol., 148(3):601-02.
14. Forschner K; Zuberbier T; <b>Worm M</b> (2002). <br><i>Benzoyl peroxide as a cause of airborne contact dermatitis in an orthopaedic worker. </i><br>Contact Dermatitis, 47:241.
15. Goetze S; Schmook T; Audring H; Ziegenbein C; <b>Worm M</b>; Schulze P (2004). <br><i>Erfolgreiche Therapie eines Stewart-Treves-Syndroms mit liposomal verkapseltem Doxorubicin. </i><br>J Dtsch Dermatol Ges., 2:49-52.
16. Schmook T; Jacobi U; Lademann J; <b>Worm M</b>; Stockfleth E (2005). <br><i>Detection of docorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia. </i><br>Dermatology, 210(3):237-238.
17. Lee HH; Sterry W; <b>Worm M</b> (2005). <br><i>Wirksamkeit von Tacrolimus-0,1-%-Salbe bei Prurigoeerkrankungen. </i><br>J Dtsch Dermatol Ges., 3:690-694.
18. von Pelchrzim R; Schmook T; Friedrich; <b>Worm M</b> (2006).<br><i>Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus. </i><br>Int J Dermatol., (1):84-85.
19. Garcia-Bartels M; Lee HH; <b>Worm M</b>; Burmester GR; Sterry W; Blume-Peytavi U. (2006). <br><i>Development of alopecia areata universalis in a patient receiving adalimumab.</i><br>Archives of Dermatology, 142(12):1654-5.
20. Oestmann E; Philipp S; Zuberbier T; <b>Worm M</b> (2007). <br><i>Colophony-induced contact dermatitis due to ECG electrodes in an infant. </i><br>Contact Dermatitis, 56(3); 177:8.
21. Meyer O; <b>Worm M</b>; Kiesewetter H; Salama A (2007). <br><i>Autoimmune thrombocytopenia in two patients with Sneddon's Syndrome.</i><br>Thromb Haemost.;98(6):1368-70
22. Werfel T; Lepp U; <b>Worm M</b> (2009). <br><i>Diskussion zum Beitrag Nahrungsmittelallergie bei Erwachsenen - über- oder unterschätzt?</i> von Seitz CS, Pfeuffer P, Raith P, Bröckner EB, Trautmann A. <br>Dtsch Arztbl, 106(7):115.
23. Breuer K; <b>Worm M</b>; Skudlik C; Schröder C; John S M (2009). <br><i>Occupational airborne contact allergy to tetrazepam in a geriatric nurse. </i><br>J Dtsch Dermatol Ges., 7(10):896-8.
24. Soost S; Zuberbier M; Zuberbier T; <b>Worm M</b> (2010). <br><i>Occupational contact dermatitis from ninhydrin in a police officer. </i><br>Contact Dermatitis, 62(1):59-60.

 

Gesamt 49,836 Impaktpunkte (Fallberichte)

Anzahl Erstautor: 8
Anzahl Letztautor: 9

Offene Sprechstunde

Das Allergie-Centrum-Charité bietet zumeist jeden 1. und 3. Mittwoch im Monat eine offene Sprechstunde an, es gibt jedoch Ausnahmen. Bitte beachten Sie hierzu unbedingt die aktuellen Hinweise auf dieser Seite.

Neue Patienten mit Überweisung können sich ohne Termin an diesen Tagen von 7:30 bis 9:00 Uhr in der Hautklinik anmelden und werden dann noch am gleichen Tag gesehen. Bitte bringen Sie jedoch Geduld und Zeit mit.

Zudem bitten wir Sie, das folgende Formular vorab zu lesen und ausgefüllt zur offenen Sprechstunde mitzubringen.

Bitte haben Sie Verständnis dafür, dass in der offenen Sprechstunde nur Erstvorstellungen möglich sind.

Hautklinik-News

Online-Patientenbefragung

08.09.2016

Kennen Sie das? Immer wenn sie Sport machen oder aus anderen Gründen ins Schwitzen kommen, bekommen sie kleine juckende Quaddeln? Wenn ja, wollen wir mehr darüber wissen! Bitte helfen sie uns und beantworten Sie unseren Fragebogen

Patienten mit Kälteurtikaria können von einer Doxycycline-Therapie profitieren

07.09.2016

M. Gorczyza, N. Schoepke, K. Krause, T. Hawro, M. Maurer

Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin, Berlin

Aktuelle Studien der Hautklinik

Patienten mit chronischer spontaner Urtikaria für Teilnahme an einer klinischen Studie gesucht

13.09.2016 Kat: Urtikaria

Erststudie des SYK-Hemmers GSK2646264 (Creme) im Menschen. Für eine klinische Studie des...

Patienten mit Kälteurtikaria für Teilnahme an einer klinischen Studie gesucht

13.09.2016 Kat: Urtikaria

Erststudie des SYK-Hemmers GSK2646264 (Creme) im Menschen. Für eine klinische Studie des...

Mastozytose - Neues Medikament zielt auf eine Verminderung und Normalisierung von Mastzellen

01.06.2016 Kat: Studien, Mastozytose

Phase-1 Studie zur Prüfung der Verträglichkeit und Wirksamkeit eines Antikörpers zur Behandlung der...

Das Allergie-Centrum-Charité ist ein zertifiziertes Comprehensive Allergy Center.

ECARF
Charité